Skip to main content
. Author manuscript; available in PMC: 2019 May 11.
Published in final edited form as: Genesis. 2018 May 11;56(5):e23212. doi: 10.1002/dvg.23212

Table 2. List of primers.

Chr 12 enhancer gRNA 1 F 5′-GTATATATTCATACAGGACGTTTT-3′
R 5′-GTCACTGTATGAATATATACCGGTG-3′

Chr 12 enhancer gRNA 2 F 5′-TCGCTGCACATTGACTCTAAGTTTT-3′
R 5′-TTAGAGTCAATGTGCAGCGACGGTG-3′

Chr 12 enhancer gRNA 3 F 5′-GGAGCTCGCTGCACATTGACGTTTT-3′
R 5′-GTCAATGTGCAGCGAGCTCCCGGTG-3′

Donor_5′arm F 5′-AGAACTAGTGGATCCCCCGGGCTGCAGGAATTCGATAT CAATTTCCCAAAAAGGAAAGGTATCTAACAAATTTATTCAC-3′
R 5′-GGGATAGGAGAGCTTAAAATCGAGCTCCAGGGTTTACT CC-3′

Donor_targeting F 5′-GGAGTAAACCCTGGAGCTCGATTTTAAGCTCTCCTATC CCATATATTTGCAATTATTTG-3′
R 5′-CCTGTCACTGTATGAATATAATAAAGCATATCTGTGTG GAGCAGAG-3′

Donor_3′arm F 5′-TCCACACAGATATGCTTTATTATATTCATACAGTGACA GGAATGACTGTCATAATAC-3′
R 5′-CCTCACTAAAGGGAACAAAAGCTGGGTACCGGGCCCCC CCGCATTTACTGTCAGTTTGTTTTACCAAAAAAATAATAAT AACTCA-3′

PCR screen for human allele F 5′-GGCCCTTAGCACTCTCTTTG-3′
R 5′-CAGCCGTCCCTGAAAATAGA-3′

PCR targeting 5′ end F 5′-TGATTTCCCAAAAAGGAAAGG-3′
R 5′-GCGAGCTCCAGGGTTTACT-3′

PCR targeting 3′ end F 5′-TTGATTGTCCTCTGCACCAC-3′
R 5′-AGGGGAAAGGAAAGACTCCA-3′

Cleav 5′ F 5′-AGCTCGCTGCACATTGACT-3′
R 5′-CCAATCACATTTTGCGACAC-3′

Cleav 3′ F 5′-TGAGGGGCTACCCATGACAT-3′
R 5′-TGCGCATCCGTTTTGTTACA-3′

gRNA3 off-target 1 F F 5′-TCTGCTCCCTGAGTGCTGTA-3′
R 5′-AGAGAAGTGCTTGGCTTCCA-3′

gRNA3 off-target 2 F F 5′-CTCTGTAGCTCGGCAGGAAC-3′
R 5′-GCTGAGCTGGAAGGATGAAC-3′

gRNA3 off-target 3 F F 5′-TCGGAGAGGAGCTACCTGAA-3′
R 5′-CCGATCCACTCCTTACCTCA-3′

gRNA3 off-target 4 F F 5′-TACCGATCCACGTCCTTCAC-3′
R 5′-CTCAACACTCGGGGTCAAGT-3′

gRNA3 off-target 5 F F 5′-CAATTTGTAGCCCTGGCTGT-3′
R 5′-CGCCATAGCTGCTTTCTACC-3′

gRNA5 off-target 1 F F 5′-GGCTTCCTTCCCTGTAGGTC-3′
R 5′-GCAATAAAGGCAGAGCTTGG-3′

gRNA5 off-target 3 F F 5′-TCTTGGGGTTTCCTACCAGA-3′
R 5′-ACTACAGGGCCCATGAGCTA-3′

gRNA5 off-target 4 F F 5′-TGCATGCCTGTTCATTAAGC-3′
R 5′-GGCAGATGGTGTCTGTAGTCC-3′

gRNA5 off-target 5 F F 5′-TCTGCATTTCTGTGGTCAGC-3′
R 5′-TTGTGAGTGAGGGTGTTGGA-3′

Rx gRNA 5′ F 5′-GGATTCGTCCCGGAGTACGAGTTTT-3′
R 5′- TGCACCTGCCGGGCTGCGCGCGGTG-3′

Rx gRNA 3′ F 5′-CGCGCAGCCCGGCAGGTGCAGTTTT-3′
R 5′-TCGTACTCCGGGACGAATCCCGGTG-3′

Rx screening F 5′-GTTTAGCTTTGGACAGACCG-3′
R 5′-GAGGTTCGGCAGTCACTGTG-3′

Arl13b gRNA 5′ F 5′-ATGGTCGGCCTTGATAATGCGTTTT-3′
R 5′-GCATTATCAAGGCCGACCATCGGTG-3′

Arl13b gRNA 3′ F 5′-TTATGGGTCATCACAACATAGTTTT-3′
R 5′-TATGTTGTGATGACCCATAACGGTG-3′

Arl13b screening F 5′- TGATACTTTCACGGGGATCG-3′
R 5′- TCCTGCTGATCAACAACTTCA-3′